Saturday, July 11, 2026

Drug profile · INN

doxapram

doxapram is a potassium channel subfamily k member 9 blocker.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — doxapram
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

doxapram is a potassium channel subfamily k member 9 blocker.

Key facts

INN doxapram
Mechanism Potassium channel subfamily K member 9 blocker

Mechanism of action

Potassium channel subfamily K member 9 blocker

Approval history

Authority Status Date
NMPA clinical trials

Frequently asked questions

What is doxapram?

doxapram is a potassium channel subfamily k member 9 blocker.